Home/Pipeline/SAGE Oncotest™

SAGE Oncotest™

Solid Tumors (Personalized Therapy Selection)

CommercialActive

Key Facts

Indication
Solid Tumors (Personalized Therapy Selection)
Phase
Commercial
Status
Active
Company

About SageMedic

SageMedic is a private, commercial-stage diagnostics company focused on functional precision oncology. Its core technology, the SAGE Oncotest™, utilizes live 3D microtumor cultures from patient biopsies to empirically test drug sensitivity, addressing a critical gap left by genomic testing alone. The company operates a CLIA-certified lab in Redwood City, CA, offering the test nationwide under physician order, positioning it as a service-based business in the growing field of personalized cancer treatment. Leadership includes physician-founders and seasoned advisors, driving a vision to improve patient outcomes by de-risking therapy selection.

View full company profile

Therapeutic Areas